Aseptic HLA B27-positive spondylodiscitis: decreased 18F-FDG uptake after etanercept treatment

Aseptic HLA B27-positive spondylodiscitis: decreased 18F-FDG uptake after etanercept treatment

We observed a 69-year old man suffering from HLA B27 ankylosing spondylitis with persistent night back pain. 18F-FDG-PET/CT showed an increased metabolism at the level of the spinal space of L2-L3, L3-L4 with increased uptake compatible with spondylodiscitis. He started therapy with etanercept 50 mg...

Full description

Bibliographic Details
Main Authors: M. Benucci, A. Damiani, A. Arena, M. Infantino, M. Manfredi, F. Li Gobbi
Format: Article
Language:English
Published: PAGEPress Publications 2016-12-01
Series:Reumatismo
Subjects:
Spondylodiscitis
etanercept
ankylosing spondylitis.
Online Access:http://www.reumatismo.org/index.php/reuma/article/view/911
Description
Summary:We observed a 69-year old man suffering from HLA B27 ankylosing spondylitis with persistent night back pain. 18F-FDG-PET/CT showed an increased metabolism at the level of the spinal space of L2-L3, L3-L4 with increased uptake compatible with spondylodiscitis. He started therapy with etanercept 50 mg/week. After six months of treatment repeated testing showed no uptake of the discs and vertebral bodies.
ISSN:0048-7449
2240-2683

Similar Items